Your Guide to Better Health
Get expert insights, health tips, and the latest updates in metabolic wellness — all in one place.
Hormones & MetabolismFDA Advisory Committee Votes to Ease Peptide Restrictions: What the July 2026 Vote on BPC-157, KPV, TB-500, and MOTS-c Actually Means
An FDA advisory committee voted on July 23, 2026 to recommend easing restrictions on four peptides — BPC-157, KPV, TB-500, and MOTS-c. Here's what that vote actually does, why it isn't an approval, and what it means for your health.
Dr. Jossy Onwude, MDJul 24, 202612 min read
Hormones & MetabolismGLP-1 and Fertility: Emerging Evidence for Women With Obesity, Insulin Resistance, and PMOS
GLP-1 fertility research in women with PMOS and insulin resistance shows consistent improvements in ovulation, menstrual regularity, and androgen levels. This deep dive covers the clinical evidence, mechanisms, who benefits most, and how to approach a PMOS fertility metabolic plan.
Editorial TeamJul 3, 202613 min read
Hormones & MetabolismIpamorelin: The Standalone Guide to the Most Selective Growth Hormone Peptide
Ipamorelin is the most selective growth hormone secretagogue available. This ipamorelin standalone guide covers its mechanism, fat loss and sleep benefits, clinical dosage protocols, side effect profile, and how it compares to GHRP-2 and GHRP-6.
Dr. Jossy Onwude, MDJul 3, 202614 min read
Lifestyle & Healthy HabitsHexarelin: The Cardioprotective Growth Hormone Peptide That Mainstream Providers Overlook
Hexarelin is the only GHRP with a dual cardioprotective mechanism via CD36 receptors. This deep dive covers the science, protocols, comparisons, and who benefits from this overlooked peptide.
Editorial TeamJul 2, 202614 min read
Hormones & MetabolismGLP-1 and Thyroid Cancer Risk: What the Evidence Actually Says (and What It Doesn't)
The semaglutide thyroid cancer risk warning appears on every GLP-1 prescription — but is it based on human evidence? This article unpacks the FDA black box warning, explains why rodent data differs from human outcomes, and reviews the latest clinical studies so you can make an informed decision.
Dr. Priyali Singh, MDJul 2, 202610 min read
Lifestyle & Healthy HabitsThe Exercise and Peptide Protocol: How to Get Maximum Results Combining Training With Therapy
The right exercise peptide therapy protocol doesn't just complement your treatment — it determines your results. This guide covers training type, peptide timing, week-by-week structure, and clinical considerations for GLP-1s, GH secretagogues, and tissue repair peptides.
Dr. Jossy Onwude, MDJul 1, 202613 min read
Hormones & MetabolismMeasuring Peptide Therapy Success: 12 Biomarkers That Matter More Than the Scale
Learn which peptide therapy biomarkers actually measure success — from IGF-1 and HOMA-IR to testosterone and liver enzymes. The scale won't show you this.
Editorial TeamJul 1, 202614 min read
Nutrition & DietOxytocin: The Forgotten Metabolic Peptide and Its Role in Appetite, Obesity, and Emotional Eating
New research on oxytocin peptide metabolic health reveals its role in appetite, emotional eating, and obesity — including the NEJM 2024 trial, brown fat activation, leptin resistance, and why it may complement GLP-1 therapy.
Karyn O.Jun 30, 202615 min read
Lifestyle & Healthy HabitsPeptide Therapy and Cancer: Addressing the Risks, the Evidence, and What Patients Should Know Before Starting
Peptide therapy cancer risk evidence is nuanced — and most telehealth platforms skip the conversation entirely. This article breaks down what the research shows for GLP-1s, GH secretagogues, and BPC-157, who carries elevated risk, and the screening every patient should complete before starting a protocol.
Lilian E.Jun 30, 202613 min read
Lifestyle & Healthy HabitsPeptides and Bone Health: What GH Peptides, GLP-1, and BPC-157 Mean for Osteoporosis Risk
Peptides and bone health don't always align the way patients expect. This deep dive covers what GH peptides, GLP-1 receptor agonists, and BPC-157 actually do to bone density and osteoporosis risk — and which biomarkers every woman over 45 on a peptide protocol should be monitoring.
Editorial TeamJun 29, 202616 min read
Lifestyle & Healthy HabitsIs Peptide Therapy Safe Long-Term? What 5+ Years of Clinical Data Tell Us
Is peptide therapy safe long term in 2026? This deep dive covers what 5+ years of GLP-1, growth hormone, and research peptide data actually shows — from cardiovascular outcomes and cancer risk to muscle loss, bone health, and what clinical oversight looks like in practice.
Dr. Priyali Singh, MDJun 29, 202612 min read
Lifestyle & Healthy HabitsUsing HSA and FSA Funds for Peptide Therapy: What Qualifies, How to Document It, and What to Avoid
HSA FSA peptide therapy eligibility in 2026 comes down to one thing: a documented medical diagnosis. This guide covers which peptide protocols qualify, how to get your Letter of Medical Necessity, the 2026 contribution limits for both accounts, and the errors that trigger IRS penalties.
Dr. Jossy Onwude, MDJun 26, 202611 min read
Hormones & MetabolismPeptide Therapy and Drug Interactions: A Clinical Reference for Patients on Other Medications
Peptide therapy drug interactions are real and specific. This clinical reference covers GLP-1 agonists, growth hormone secretagogues, and tissue repair peptides — organized by drug class, so you know what to monitor and what to discuss with your clinician before starting any protocol.
Editorial TeamJun 26, 202617 min read
Lifestyle & Healthy HabitsVIP Peptide (Vasoactive Intestinal Peptide): Benefits, Mechanism, and What It Means for Gut and Inflammatory Health
VIP peptide — vasoactive intestinal peptide — is one of the body's most potent anti-inflammatory compounds. This pillar guide covers its mechanism, gut and immune benefits, neuroinflammation applications, safety profile, and clinical protocols for IBS, IBD, CIRS, and beyond.
Dr. Priyali Singh, MDJun 25, 202614 min read
Weight ManagementWhy You've Hit a Weight Loss Plateau on GLP-1: Root Causes and Peptide-Based Solutions
A GLP-1 weight loss plateau on semaglutide is common — and fixable. This deep dive covers the root biological causes, from metabolic adaptation to hormonal interference, and the peptide-based and clinical strategies that help you break through and keep losing.
Karyn O.Jun 25, 202614 min read
Weight ManagementWhat Happens When You Stop Semaglutide: Weight Regain, Metabolic Reversal, and What the Science Says
Stopping semaglutide triggers rapid weight regain and metabolic reversal in most patients. Here's what the clinical evidence actually shows — and what a long-term strategy looks like.
Dr. Jossy Onwude, MDJun 24, 202613 min read
Lifestyle & Healthy HabitsCompounded vs Brand-Name Peptides: What You're Really Paying For (and What You're Risking)
Compounded peptide vs brand name cost: the price gap can be 80–90%. But what matters is what you're getting for that price — and what you may be risking. This guide breaks down real costs, pharmacy quality standards, FDA regulations in 2026, and how to make a safe, informed decision.
Dr. Priyali Singh, MDJun 24, 202611 min read
Sleep & RecoveryGLP-1 and Sleep Apnea: What the Retatrutide TRIUMPH Data Means for Patients With Metabolic Sleep Disorders
GLP-1 peptides for sleep apnea treatment now have Phase 3 backing. Retatrutide's TRIUMPH-1 OSA basket data (ADA 2026) showed a 60.6% AHI reduction. This deep dive covers the mechanism, the data, how it compares to tirzepatide, and what patients with metabolic sleep disorders need to know now.
Lilian E.Jun 23, 202614 min read